ArticleInvestigational new drugs2013

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study.

Normand Blais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.